Schwann cells harbor the somatic NF1 mutation in neurofibromas: Evidence of two different Schwann cell subpopulations

Human Molecular Genetics

Volumn 9, Issue 20, 2000, Pages 3055-3064

  Serra, Eduard ^a   Rosenbaum, Thorsten ^b   Winner, Ursula ^b   Aledo, Rosa ^c   Ars, Elisabet ^a   Estivill, Xavier ^a   Lenard, Hans Gerd ^b   Lázaro, Conxi ^a  

^a HOSPITAL DURAN I REYNALS   (Spain)

^b HEINRICH HEINE UNIVERSITY   (Germany)

^c UNIVERSITAT INTERNACIONAL DE CATALUNYA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

NEUROFIBROMIN;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CELL SUBPOPULATION; CELL TYPE; CLINICAL ARTICLE; CONTROLLED STUDY; FIBROBLAST; GENE LOCUS; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; NEUROFIBROMA; NEUROFIBROMATOSIS; PRIORITY JOURNAL; SCHWANN CELL; SOMATIC MUTATION; TUMOR SUPPRESSOR GENE;

EID: 0034642298     PISSN: 09646906     EISSN: None     Source Type: Journal    
DOI: 10.1093/hmg/9.20.3055     Document Type: Article

References (54)

1. A genetic study of von Recklinghausen neurofibromatosis in South East Wales I: Prevalence, fitness, mutation rate and effect of parental transmission on severity
2. A major segment of the neurofibromatosis type I gene: CDNA sequence, genomic structure and point mutations
3. Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type 1 locus
4. Type 1 neurofibromatosis gene: Identification of a large transcript disrupted in three NF1 patients
5. Genomic organization of the neurofibromatosis 1 gene (NF1)
6. The NF1 locus encodes a protein functionally related to GAP and yeast IRA proteins
7. The GAP-related domain of the NF1 gene interacts with ras p21
8. The neurofibromatosis type 1 gene encodes a protein related to GAP
9. The catalytic domain of the neurofibromatosis type 1 gene product stimulates Ras GTPase and complements IRA mutants of S. cerevisiae
10. Differential regulation of Ras GAP and neurofibromatosis gene product activities
11. Identification and characterization of the neurofibromatosis type 1 protein product
12. Abnormal regulation of mammalian p21ras contributes to malignant tumor growth in von Recklinghausen (type 1) neurofibromatosis
13. Aberrant regulation of ras proteins in malignant tumour cells from type 1 neurofibromatosis patients
14. Requirement of Drosophila NF1 for activation of adenylyl cyclase by PACAP38-like neuropeptides
15. Rescue of a Drosophila NF1 mutant phenotype by protein kinase A
16. Identification of NF1 mutations in both alleles of a dermal neurofibroma
17. Toward a survey of somatic mutation of the NF1 gene in benign neurofibromas of patients with neurofibromatosis type 1
18. A search for evidence of somatic mutations in the NF1 gene
19. Benign neurofibromas in type neurofibromatosis (NF1) show somatic deletions of the NF1 gene
20. Confirmation of a double-hit model for the NF1 gene in benign neurofibromas
21. Clonal origin of tumor cells in a plexiform neurofibroma with LOH in NF1 intron 38 and in dermal neurofibromas without LOH of the NF1 gene
22. Allelic loss of the NF1 gene in NF1-associated plexiform neurofibromas
23. Cell culture studies on neurofibromatosis (von Recklinghausen). II. Occurrence of glial cells in primary cultures of peripheral neurofibromas
24. Cellular differentiation and expression of matrix genes in type 1 neurofibromatosis
25. The neurofibroma in von Recklinghausen neurofibromatosis has a unicellular origin
26. Culture of cytogenetically abnormal schwann cells from benign and malignant NF1 tumors
27. Loss of NF1 allele in Schwann cells but not in fibroblasts derived from an NF1-associated neurofibroma
28. Genetic and cellular defects contributing to benign tumor formation in neurofibromatosis type 1
29. Angiogenic and invasive properties of neurofibroma Schwann cells
30. CAMP-dependent protein kinase A is required for Schwann cell growth: Interactions between the cAMP and neuregulin-tyrosine kinase pathways
31. Purification and expansion of human Schwann cells in vitro
32. Improved culture methods to expand Schwann cells with altered growth behaviour from CMT1A patients
33. Long-term culture and characterization of human neurofibroma-derived Schwann cells
34. NF1 mutations affecting mRNA splicing are the most common molecular defects in patients with neurofibromatosis type 1
35. Synergistic regulation of Schwann cell proliferation by heregulin and forskolin
36. Forskolin: A unique diterpene activator of cyclic AMP-generating systems
37. Growth of a neuroblastoma cell line in serum free supplemented medium
38. Neurofibromin-deficient fibroblasts fail to form perineurium in vitro
39. The NF1 tumor suppressor regulates mouse skin wound healing, fibroblast proliferation and collagen deposited by fibroblasts
40. Schwann cells from neurofibromin deficient mice exhibit activation of p21ras, inhibition of cell proliferation and morphological changes
41. NF1-deficient mouse Schwann cells are angiogenic and invasive and can be induced to hyperproliferate: Reversion of some phenotypes by an inhibitor of farnesyl protein transferase
42. Ras-GTP levels are elevated in human NF1 peripheral nerve tumors
43. Single cell Ras-GTP analysis reveals altered Ras activity in a subpopulation of neurofibroma Schwann cells but not fibroblasts
44. Cyclic AMP as a mitogenic signal for cultured rat Schwann cells
45. Schwann cell galactocerebroside induced by derivatives of adenosine 3',5'-monophosphate
46. Tissue culture studies of neurofibromatosis: Effects of axolemmal fragments and cyclic adenosine 3',5'-monophosphate analogues on proliferation of Schwann-like and fibroblast-like neurofibroma cells
47. Schwann cell responses to cyclic AMP: Proliferation, change in shape and appearance of surface galactocerebroside
48. +, GFAP-, N-CAM-, NGF-receptor-) depends on growth inhibition
49. Tissue culture studies of Schwann cell proliferation and differentiation
50. Modulation of the neurofibromatosis type 1 gene product, neurofibromin, during Schwann cell differentiation
51. Neurofibromin, the neurofibromatosis type 1 (NF1) Ras-GAP, is required for appropriate P0 expression and myelination
52. Differential expression of two mRNA species indicates a dual function of peripheral myelin protein PMP22 in cell growth and myelination